Patrick Marshall - 12 Feb 2025 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role: Director
Signature: /s/ Stephen Lemieux, Attorney-in-Fact for Patrick Marshall
Issuer symbol: EDSA
Transactions as of: 12 Feb 2025
Net transactions value: +$79,999
Form type: 4
Filing time: 14 Feb 2025, 17:01:23 UTC
Previous filing: 24 Jul 2023
Next filing: 02 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EDSA	Common Shares	Award	$79,999	+41,666		$1.92	41,666	12 Feb 2025	Direct	F1
holding	EDSA	Common Shares						465	12 Feb 2025	Held by Quidnet Inc.	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 12, 2025, the Reporting Person purchased in a private placement, 41,666 common shares, without par value, of the Issuer, for a purchase price of $1.92 per share.
F2	Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023.
F3	Quidnet Inc. is wholly owned by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Remarks:

Ex. 24 - Power of Attorney